Cargando…

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)

CGM is a useful tool in Type 1diabetes management. Its use reduces the frequency of insulin induced hypoglycemia and improves A1c values. Differences between venous, plasma, and interstitial fluid glucose values and “drift” in factory calibrated CGM sensors have rendered difficult quantifying glucos...

Descripción completa

Detalles Bibliográficos
Autor principal:	Melish, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553233/ http://dx.doi.org/10.1210/js.2019-SUN-146

Ejemplares similares

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

SUN-LB035 Blood Glucose Trends Documented by Continuous Glucose Monitors Can Be Foundational in the Diagnostic Evaluation of MODY 2
por: Addala, Ananta, et al.
Publicado: (2019)

SAT-146 Short-Term Optimization of Glucose Control Using Self-Monitored Blood Glucose and Standard Therapies
por: Zelada, Henry, et al.
Publicado: (2019)

SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023)

ODP210 Impact of Continuous Glucose Monitoring (CGM) in the Intensive Care Units (ICUs): Accuracy, Reliability, Feasibility and Nurse Acceptance
por: del Rincon, Juan, et al.
Publicado: (2022)

SAT-127 Hypoglycemic Episodes in Type 2 Diabetes Mellitus : Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose
por: Aung, Tin, et al.
Publicado: (2019)

SAT-640 Glycemic Profile of Intravenous Glucocorticoid Induced Hyperglycemia Using Continuous Glucose Monitoring
por: Zhang, Fan, et al.
Publicado: (2020)

SAT-644 A Case of the Use of the Eversense Continuous Glucose Monitor with Repeated Same-Pocket Insertion
por: Lee, Warren, et al.
Publicado: (2020)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

SAT-645 An Indication for Continuous Glucose Monitoring in Glucocorticoid-Treated Patients with Diabetes Mellitus
por: Sandhu, Harjyot, et al.
Publicado: (2020)

SUN-657 The Effect of Simvastatin on Glucose Metabolism in Primary Human Muscle Cells
por: Mäkinen, Selina, et al.
Publicado: (2020)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

SUN-188 Contributing Factors Precipitation Diabetic Ketoacidosis in Patients Using Sodium-Glucose Cotransporter-2 Inhibitor
por: Attia, Jonven, et al.
Publicado: (2019)

SUN-670 P300 and CBP Are Necessary for Skeletal Muscle Insulin-Stimulated Glucose Uptake
por: Martins, Vitor Fernandes, et al.
Publicado: (2020)

OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
por: Carlson, Anders, et al.
Publicado: (2019)

Implementation of a Continuous Glucose Monitoring Program at a Safety Net Hospital During Covid 19 Pandemic
por: Finn, Erin E, et al.
Publicado: (2021)

MON-183 Comparison of Continuous Glucose Monitor versus Meal Tolerance Test for Detection of Post-Bariatric Surgery Hypoglycemia
por: Lee, Clare, et al.
Publicado: (2019)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Usefulness of the Continuous Glucose Monitoring (Freestyle Device) to Assess Glycemic Control of Diabetic Patients With and Without COVID 19 in a Hospital of Bogotá Colombia
por: Medina, Adriana, et al.
Publicado: (2021)

SUN-149 Cardiologist vs. Endocrinologist Encounters in Patients with T2D and CVD: Potential Implications for Glucose-Lowering Therapy Use and Education
por: Gunawan, Felona, et al.
Publicado: (2019)

SAT-638 An Academic Center Experience with the Eversense Continuous Glucose Monitoring System and Assessment of Intrapatient Variability with Repeated Same-Pocket Insertion
por: Lee, Warren, et al.
Publicado: (2020)

SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

SUN-LB121 Nifedipine Worsens Glucose Tolerance in C57BL/6J Mice Exposed to Intermittent Hypoxia
por: Cardenas, Stanley M Chen, et al.
Publicado: (2020)

SUN-616 Poor Diagnostic Concordance Between Fasting Plasma Glucose and Glycosylated Hemoglobin in a Black South African Population
por: Wade, Alisha N, et al.
Publicado: (2020)

MON-180 Evaluation of the GLUCOCARD Shine Express Audio Enabled Blood Glucose Monitoring System's Ease of Use
por: Walker, Julie, et al.
Publicado: (2019)

Predictors of Normalization of Fasting Glucose in Patients With Prediabetes Using Remote Continuous Care Emphasizing Low Carbohydrate Intake
por: McKenzie, Amy, et al.
Publicado: (2021)

SAT-128 Evaluating the Accuracy of Glycemic Markers and Risk of Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease by Continuous Glucose Monitoring
por: Presswala, Lubaina, et al.
Publicado: (2019)

SAT-639 Is the Freestyle Libre Flash Glucose Monitor Accurate in the Critically Ill?
por: Johnson-Rabbett, Brianna, et al.
Publicado: (2020)

SAT-131 Success of CME/CE in Promoting Practice Improvements in the Use of New Technologies for Glucose Monitoring
por: Larkin, Amy, et al.
Publicado: (2019)

SUN-LB024 Elevation in Morning Glucose Level May Be a Signal for the Development of Immune Checkpoint Inhibitor (ICPi) Induced Autoimmune Diabetes Insulin
por: Zhang, Amy, et al.
Publicado: (2019)

SUN-618 Decision Analysis for Glucagon-Like Peptide Receptor Agonists vs. Sodium-Glucose cotransporter2 Inhibitors in Type 2 Diabetes Mellitus
por: khazaali, Ali Al, et al.
Publicado: (2020)

MON-181 Evaluation of the GLUCOCARD Shine Connex Bluetooth Enabled Blood Glucose Monitoring System's Ease of Use
por: Walker, Julie, et al.
Publicado: (2019)

SAT-648 Flash Glucose Monitoring Helps Achieve Better Glycemic Control Than Conventional Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes: A Randomized Controlled Trial
por: Wada, Eri, et al.
Publicado: (2020)

THU276 The Use of Continuous Glucose Monitors for Management of Postbariatric Hypoglycemia
por: Jani, Shivani, et al.
Publicado: (2023)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

MON-639 Melanocortin 4 Receptor Contributes to Glucose Homeostasis by Regulating Kidney Glucose Reabsorption via the Glucose Transporter GLUT2
por: de Souza Cordeiro, Leticia M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49e2k8q04ibqeqtmhh8laos4qv